AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Director's Dealing Sep 8, 2020

3377_rpt_2020-09-08_8fe54b36-a534-44f8-ac5d-324e8ec40604.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.

Details of the person discharging managerial responsibilities/person closely associated
Name Claus Crone Fuglsang +45 3077 8682
Reason for notification Carl Ahlgren
Position/status CSO and Executive Vice President, Research & Development +45 3077 2783
Initial notification/
amendment
Initial notification Ulrik Wu Svare
Details of the issuer +45 3077 3187
Entity Novozymes A/S
LEI code 529900T6WNZXD2R3JW38

Details of the transaction(s)

Description:
Financial instrument Shares
Identification code ISIN DK0060336014
Nature of the transaction Purchase of shares from exercise of stock options
Place(s) of transaction(s),
price(s) and volume(s)
Place(s)
Novozymes' custody account
Novozymes' custody account
Price(s)
300.90
273.60
Volume(s)
7,311 shares
7,632 shares
Aggregated information Number of shares: 14,943
Average price, DKK: 287,00
Transaction value, DKK: 4,287,995.10
Date of the transaction 2020-08-09 09:24 CEST

September 8, 2020 Company announcement No. 57

Contact information [email protected]

Tobias Cornelius Björklund [email protected]

[email protected]

[email protected]

About Novozymes

Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38

Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark

Phone: +45 4446 0000

Details of the person discharging managerial responsibilities/person closely associated

Name Claus Crone Fuglsang

Reason for notification

Position/status CSO and Executive Vice President, Research & Development
Initial notification/ Initial notification
amendment

Details of the issuer

Entity Novozymes A/S
LEI code 529900T6WNZXD2R3JW38

Details of the transaction(s)

Description:
Financial instrument Shares
Identification code ISIN DK0060336014
Nature of the transaction Shares sold
Place(s) of transaction(s),
price(s) and volume(s) Place(s) Price(s) Volume(s)
See appendix See appendix 11,264 shares
Aggregated information Number of shares: 11,264
Average price, DKK: 384.65
Transaction value, DKK: 4,332,684.09
Date of the transaction 2020-08-09

Appendix

Date & Time Volume Price Venue
09-08-20 09:24:44 3,532 384.65 XCSE
09-08-20 09:24:44 1,964 384.65 XCSE
09-08-20 09:24:44 971 384.65 XCSE
09-08-20 09:24:44 2,724 384.65 XCSE
09-08-20 09:24:44 1,250 384.65 XCSE
09-08-20 09:24:44 733 384.65 XCSE
09-08-20 09:24:45 90 384.50 XCSE

Talk to a Data Expert

Have a question? We'll get back to you promptly.